Elanco Animal Health Executive Vice President Rajeev Modi Acquires Deferred Stock Units

Details of the Deferred Stock Unit Transaction

The disclosure filed on July 28, 2026, details the acquisition of deferred stock units by Rajeev A. Modi, who serves as Executive Vice President of U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc. The transaction took place on July 24, 2026, and involved the acquisition of 59.2906 deferred stock units. The filing indicates that the price associated with these units was $24.91 per unit, representing a component of the executive's compensation package.

Following this transaction, Modi's total beneficial ownership of deferred stock units reached 9,641.9274 units. The units were acquired directly, as indicated by the "D" designation for direct ownership in the filing. These deferred stock units represent equity compensation that vests and settles according to the terms of Elanco's Executive Deferral and Stock Match Plan, providing executives with a mechanism to defer portions of their compensation while maintaining exposure to company stock performance.

Structure and Settlement of Deferred Stock Units

According to the disclosure, each deferred stock unit represents the right to receive one share of Elanco Animal Health common stock or the cash equivalent thereof. This structure provides flexibility in how compensation is ultimately delivered to the executive. The units are not immediately converted to shares but rather are held in deferred status, allowing the executive and the company to manage tax implications and timing of compensation delivery.

The filing explains that deferred stock units settle in cash or shares of company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan. This arrangement is a common practice among publicly traded companies seeking to align executive compensation with long-term shareholder interests while providing executives with predictable deferred compensation structures. The settlement provisions allow executives to plan for the eventual receipt of their compensation while remaining subject to company-specific vesting and settlement schedules.

Executive Role and Responsibilities

Rajeev A. Modi holds the position of Executive Vice President responsible for U.S. Pet Health and Global Digital Transformation at Elanco Animal Health. This role places Modi among the company's senior leadership team with significant responsibilities spanning both the U.S. pet health business segment and enterprise-wide digital transformation initiatives. The combination of these two strategic areas suggests Modi's involvement in modernizing the company's operations while managing a critical business unit within the animal health sector.

The acquisition of deferred stock units as disclosed in this Form 4 filing indicates Modi's continued participation in the company's equity compensation programs. Such acquisitions are typically part of annual or periodic grants to executives as recognition of their roles and contributions to the organization. The size of Modi's beneficial ownership position, totaling over 9,600 units, reflects his tenure and status within the company's executive hierarchy.

Insider Trading Reporting Requirements

The disclosure represents compliance with Section 16(a) of the Securities Exchange Act of 1934, which requires directors, officers, and beneficial owners of more than ten percent of a registered company's equity securities to report changes in their beneficial ownership within specified timeframes. The filing was executed by Amy C. Seidel, acting as attorney-in-fact for Modi, and was filed with the Securities and Exchange Commission on July 28, 2026, four days after the transaction date. This timing demonstrates adherence to the typical regulatory reporting schedule for insider transactions.

Form 4 filings provide public investors with transparency regarding equity transactions by company insiders. These disclosures help investors monitor the trading activity and investment decisions of executives and other company stakeholders. The information contained in insider transaction reports can provide context regarding management's confidence in the company and their investment decisions, though such filings are required disclosures rather than voluntary recommendations to investors.

Compensation Structure in the Animal Health Industry

Deferred stock units represent a significant component of executive compensation strategies in the animal health and pharmaceutical industries. By linking executive compensation to the company's stock performance through deferred equity awards, companies like Elanco create alignment between executive and shareholder interests. The deferred nature of the units allows executives to manage the timing and tax consequences of compensation receipt while maintaining meaningful exposure to long-term stock performance.

The animal health sector, which includes companies like Elanco, operates in a competitive market serving veterinarians, pet owners, and agricultural producers. Retaining experienced executives with deep industry knowledge and operational expertise requires competitive compensation packages that often include equity-based components. Modi's significant beneficial ownership position, evidenced by the over 9,600 deferred stock units disclosed in this filing, reflects his status as a key member of the company's executive leadership team overseeing critical business and transformation initiatives.

Elanco Animal Health Background

Elanco Animal Health Inc. is a publicly traded company listed on the New York Stock Exchange under the ticker symbol ELAN. The company operates in the animal health sector, providing products and services for companion animals and livestock. With headquarters in Indianapolis, Indiana, Elanco serves a diverse customer base including veterinary professionals, pet owners, and agricultural operations across multiple geographic markets.

The company's operations span both pet health and livestock health segments, with strategic initiatives focused on digital transformation and market expansion. Executives like Rajeev Modi hold responsibility for significant business units and enterprise-wide transformation efforts aimed at enhancing operational efficiency, market reach, and customer engagement. The animal health industry continues to experience growth driven by increasing pet ownership, rising spending on pet healthcare, and the importance of livestock health in global food production.

Regulatory Context and Transparency

The disclosure of insider transactions through Form 4 filings represents a cornerstone of securities law transparency requirements in the United States. These reports allow the public and regulatory authorities to monitor trading activity by company insiders, potentially identifying patterns that could indicate material nonpublic information or conflicts of interest. The SEC maintains a database of all Form 4 filings, making this information publicly available through its EDGAR system.

Investors analyzing insider transactions should consider that such filings may reflect routine compensation matters, strategic positioning, or personal financial planning rather than indicating particular views about the company's future prospects. In the case of Modi's deferred stock unit acquisition, the transaction appears consistent with equity compensation practices for senior executives. The regularized nature of such grants as part of compensation programs distinguishes them from discretionary open market purchases that might carry different analytical implications.

Beneficial Ownership Disclosure Requirements

The Form 4 filing details Modi's total beneficial ownership of deferred stock units following the reported transaction. Beneficial ownership encompasses both direct ownership and indirect ownership interests, including holdings through trusts, family entities, or other arrangements. In this case, Modi's beneficial ownership is held directly, as indicated by the filing. The disclosure of cumulative beneficial ownership provides investors with a complete picture of an executive's equity stake in the company, which may be relevant to evaluating potential conflicts of interest or alignment with shareholder interests.

The substantial beneficial ownership position disclosed—over 9,600 deferred stock units—represents a meaningful equity stake for Modi. While these units have not yet settled into common shares, they represent potential future ownership and economic interest in the company. The deferred settlement structure means that the full economic benefit and voting rights associated with these units will be realized only upon settlement following termination of employment or during specified future periods as outlined in the Executive Deferral and Stock Match Plan.